As artificial intelligence increasingly integrates into everyday life, its growing presence in the healthcare sector raises important questions. Health insurers often utilize AI to identify fraudulent claims, but concerns loom over its potential use to deny valid claims. In Texas, lawmakers are preparing to debate the extent to which AI technology should be permitted in health insurance practices.

Patient advocate Michele Rayes, who has hypoparathyroidism, shared her troubling experience with the claims process for a necessary medication. Despite navigating through the prior authorization steps, her claim faced repeated denials, ultimately leading her to discover that an AI system had taken preliminary actions on her claim prior to any human intervention.

Rayes emphasizes the need for a case-by-case analysis for claims involving medical needs, arguing against blanket denials based on generalized data processes. Her experience underscores the complexity of using AI in healthcare, where individual circumstances can significantly impact outcomes.

At the Texas State Capitol, Senator Charles Schwertner, a Republican and practicing physician, has introduced Senate Bill 815. This proposed legislation seeks to prohibit health insurers from relying solely on AI to deny, modify, or delay claims. Schwertner expressed concerns that current AI implementations prioritize insurer profits over patient well-being, allowing automated systems to trigger mass claim reevaluations without adequate human review.

The bill could empower the Texas Department of Insurance to investigate AI usage in claims and mandates increased transparency regarding the decision-making processes for patients.

While some legislators support Schwertner’s bill, others, including Senator Lois Kolkhorst, voiced apprehension over the broad definitions that might unintentionally hinder state programs like Medicaid and CHIP in their efforts to combat fraud and “up-coding” practices in billing. The Texas Association of Health Plans echoed these concerns, stating that limiting AI could undermine valuable tools used to detect billing errors and combat fraudulent activities, essential for controlling healthcare costs.

In his statement, Jamie Dudensing, president of the Texas Association of Health Plans, noted the importance of AI capabilities in analyzing large datasets to identify discrepancies and potential fraud.

Despite the concerns raised, the Texas Medical Association publicly supported Schwertner’s legislation, positing that it could help prevent instances of “down-coding,” where insurers might deny coverage for necessary care that has been properly recommended by physicians, effectively saving insurance companies money.

Dr. “Zeke” Silva, representing the Texas Medical Association, remarked on the sophisticated nature of AI technology, stating that the current advancements exceed prior predictions. He reassured committee members that nothing in the proposed bill would prevent continued fraud investigations.

The ongoing tensions between doctor groups and health insurance organizations in Texas frequently arise over payment disputes, liability, and the scope of medical practice. As the bill remains pending in committee, further discussions will determine how best to balance technological advancements with the necessity of protecting patient rights within the healthcare system.